kabutan

Kohjin Bio Co.,Ltd.(177A) Summary

177A
TSE Growth
Kohjin Bio Co.,Ltd.
1,286
JPY
+1
(+0.08%)
Jan 29, 1:01 pm JST
8.41
USD
Jan 28, 11:01 pm EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.0
PBR
1.13
Yield
1.94%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,282 JPY 8.37 USD
Previous Close Jan 28
1,285 JPY 8.41 USD
High Jan 29, 9:41 am
1,293 JPY 8.45 USD
Low Jan 29, 9:05 am
1,280 JPY 8.36 USD
Volume
8,600
Trading Value
0.01B JPY 0.07M USD
VWAP
1282.74 JPY 8.38 USD
Minimum Trading Value
128,600 JPY 841 USD
Market Cap
6.57B JPY 0.04B USD
Number of Trades
38
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
50
1-Year High Aug 27, 2025
1,762
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 82,000
Jan 16, 2026 0 82,100
Jan 9, 2026 0 78,400
Dec 26, 2025 0 117,000
Dec 19, 2025 0 118,800
Company Profile
Kohjin Bio Co., Ltd. specializes in the development, manufacturing, and sales of cell culture media, as well as contract manufacturing of cell-processed products.
Sector
Chemicals
Kohjin Bio Co., Ltd. primarily focuses on the manufacturing and sales of bacterial culture media, in vitro diagnostic pharmaceuticals, and cell culture media, while also emphasizing regenerative medicine. The company particularly concentrates on developing and selling serum-free media, providing culture media for stem cells and immune cells. Additionally, they manufacture and sell antigen test kits for COVID-19 and influenza. In their cell processing business, Kohjin Bio manufactures specific cell-processed products commissioned by medical institutions and offers regulatory compliance support for regenerative medicine. Working in collaboration with domestic and international group companies, Kohjin Bio provides a wide range of products and services related to microbial testing and regenerative medicine.